K950227

Substantially Equivalent

RUBELISA (RUBESTAT)

Applicant: Bio-Whittaker, Inc., A Cambrex Co.
Product code: LFX
Advisory panel: Microbiology
Date received: 1995-01-10
Decision date: 1995-08-15
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Walkersville, MD, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.